Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armando Santoro

Showing results (1-10 of 626) with videos related to

Pageof 63
Sort By:
Blood|January 13, 2011
How I treat: diagnosing and managing "in situ" lymphomaAntonino Carbone, Armando Santoro
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
The present and the future landscape of treatment of advanced hepatocellular carcinomaLorenza Rimassa, Armando Santoro
The New England Journal of Medicine|January 7, 2006
Antibacterial prophylaxis in patients with cancer and neutropeniaLuca Castagna, Armando Santoro
Expert Review of Anticancer Therapy|June 6, 2009
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trialLorenza Rimassa, Armando Santoro
Annals of Translational Medicine|September 21, 2020
Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?Monica Balzarotti, Armando Santoro
Annals of Translational Medicine|December 14, 2020
Erratum to checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?Monica Balzarotti, Armando Santoro
Biomarkers in Medicine|July 31, 2015
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphomaCarmelo Carlo-Stella, Armando Santoro
The New England Journal of Medicine|February 14, 2006
Trastuzumab in breast cancerGiuseppe L Banna, Armando Santoro
Drugs|February 21, 2009
Sorafenib: a review of its use in advanced hepatocellular carcinomaGillian M Keating, Armando Santoro
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
LymphomasArmando Santoro, Monica Balzarotti, Luca Castagna
Pageof 63

Showing results (1-10 of 626) with videos related to

Sort By:
Pageof 63
Blood|January 13, 2011
How I treat: diagnosing and managing "in situ" lymphomaAntonino Carbone, Armando Santoro
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 16, 2010
The present and the future landscape of treatment of advanced hepatocellular carcinomaLorenza Rimassa, Armando Santoro
The New England Journal of Medicine|January 7, 2006
Antibacterial prophylaxis in patients with cancer and neutropeniaLuca Castagna, Armando Santoro
Expert Review of Anticancer Therapy|June 6, 2009
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trialLorenza Rimassa, Armando Santoro
Annals of Translational Medicine|September 21, 2020
Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?Monica Balzarotti, Armando Santoro
Annals of Translational Medicine|December 14, 2020
Erratum to checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?Monica Balzarotti, Armando Santoro
Biomarkers in Medicine|July 31, 2015
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphomaCarmelo Carlo-Stella, Armando Santoro
The New England Journal of Medicine|February 14, 2006
Trastuzumab in breast cancerGiuseppe L Banna, Armando Santoro
Drugs|February 21, 2009
Sorafenib: a review of its use in advanced hepatocellular carcinomaGillian M Keating, Armando Santoro
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
LymphomasArmando Santoro, Monica Balzarotti, Luca Castagna
Pageof 63